These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9364984)

  • 41. Factor VIIa/tissue factor generates a form of factor V with unchanged specific activity, resistance to activation by thrombin, and increased sensitivity to activated protein C.
    Safa O; Morrissey JH; Esmon CT; Esmon NL
    Biochemistry; 1999 Feb; 38(6):1829-37. PubMed ID: 10026263
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The use of fluorogenic substrates to monitor thrombin generation for the analysis of plasma and whole blood coagulation.
    Ramjee MK
    Anal Biochem; 2000 Jan; 277(1):11-8. PubMed ID: 10610684
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isolation of a proteinase with plasminogen-activating activity from Lachesis muta muta (bushmaster) snake venom.
    Sanchez EF; Santos CI; Magalhaes A; Diniz CR; Figueiredo S; Gilroy J; Richardson M
    Arch Biochem Biophys; 2000 Jun; 378(1):131-41. PubMed ID: 10871053
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [ANSA analysis. V. Secondary specificity of peptidases to the structure of detected groups of aminonaphthalenesulfamide chromogenic substrates].
    Nedospasov AA; Rodina EV; Cherkasov AV
    Biokhimiia; 1994 Oct; 59(10):1560-73. PubMed ID: 7819397
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Medium effects on the kinetics of human plasmin.
    Yang H
    Thromb Res; 1992 Feb; 65(3):377-88. PubMed ID: 1385909
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
    Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ
    J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A continuous spectrophotometric assay for the hepatitis C virus serine protease.
    Zhang R; Beyer BM; Durkin J; Ingram R; Njoroge FG; Windsor WT; Malcolm BA
    Anal Biochem; 1999 Jun; 270(2):268-75. PubMed ID: 10334844
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Engineered recombinant factor VII Q217 variants with altered inhibitor specificities.
    Chang YJ; Hamaguchi N; Chang SC; Ruf W; Shen MC; Lin SW
    Biochemistry; 1999 Aug; 38(34):10940-8. PubMed ID: 10460149
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [New donor-acceptor pairs for fluorogenic substrates with intramolecular fluorescence energy transfer for thrombin and trypsin].
    Kholodovich VV; Kara DI; Gershkovich AA; Kibirev VK; Karabut LV; Klimenko IV; Korneliuk AI
    Bioorg Khim; 1998 Mar; 24(3):179-85. PubMed ID: 9612559
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH; Rijken DC
    Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structure/function analyses of recombinant variants of human factor Xa: factor Xa incorporation into prothrombinase on the thrombin-activated platelet surface is not mimicked by synthetic phospholipid vesicles.
    Larson PJ; Camire RM; Wong D; Fasano NC; Monroe DM; Tracy PB; High KA
    Biochemistry; 1998 Apr; 37(14):5029-38. PubMed ID: 9538022
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design and characterization of dipetacompinR10H, a dipetalogastin II-derived, classical competitive thrombin inhibitor.
    Bitter T; López M; Nowak G
    Thromb Haemost; 2007 Jan; 97(1):139-45. PubMed ID: 17200781
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enzymatic characterization of membrane-associated hepatitis C virus NS3-4A heterocomplex serine protease activity expressed in human cells.
    Hamill P; Jean F
    Biochemistry; 2005 May; 44(17):6586-96. PubMed ID: 15850392
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [ANSA analysis. III. Synthesis of aminonaphthalinesulfonamide chromogenic substrates for protease analysis].
    Kazantsev AG; Kuznetsov NV; Iakhimovich AD; Sharina IG; Nezavibat'ko VN; Nedospasov AA
    Biokhimiia; 1994 Oct; 59(10):1535-43. PubMed ID: 7819395
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High throughput substrate specificity profiling of serine and cysteine proteases using solution-phase fluorogenic peptide microarrays.
    Gosalia DN; Salisbury CM; Ellman JA; Diamond SL
    Mol Cell Proteomics; 2005 May; 4(5):626-36. PubMed ID: 15705970
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New fluorogenic substrates for alpha-thrombin, factor Xa, kallikreins, and urokinase.
    Morita T; Kato H; Iwanaga S; Takada K; Kimura T
    J Biochem; 1977 Nov; 82(5):1495-8. PubMed ID: 591514
    [TBL] [Abstract][Full Text] [Related]  

  • 57. N-ethoxycarbonyl-D-phenylalanyl-L-prolyl-alpha-azalysine p-nitrophenyl ester: a novel, high selective and optimal chromogenic active site titrant for human and bovine alpha-, beta- and gamma-thrombin.
    Balliano G; Milla P; Giordano C; Gallina C; Coletta M; Menegatti E; Rizzi M; Bolognesi M; Ascenzi P
    Biochem Biophys Res Commun; 1996 Aug; 225(2):557-61. PubMed ID: 8753800
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enzymatic investigation for delayed-type hypersensitivity reaction. Assay for thrombin and plasmin activities in tuberculin reaction sites.
    Imamura T; Kambara T
    Acta Pathol Jpn; 1991 Oct; 41(10):722-9. PubMed ID: 1725944
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assay of coagulation proteases using peptide chromogenic and fluorogenic substrates.
    Lottenberg R; Christensen U; Jackson CM; Coleman PL
    Methods Enzymol; 1981; 80 Pt C():341-61. PubMed ID: 6210826
    [No Abstract]   [Full Text] [Related]  

  • 60. Localization of a heparin binding site in the catalytic domain of factor XIa.
    Badellino KO; Walsh PN
    Biochemistry; 2001 Jun; 40(25):7569-80. PubMed ID: 11412111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.